These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035 [TBL] [Abstract][Full Text] [Related]
4. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging. Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278 [TBL] [Abstract][Full Text] [Related]
5. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging--a case report. Krinsky GA; Theise ND; Rofsky NM; Mizrachi H; Tepperman LW; Weinreb JC Radiology; 1998 Nov; 209(2):461-4. PubMed ID: 9807574 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Ito K; Mitchell DG; Gabata T; Hann HW; Kim PN; Fujita T; Awaya H; Honjo K; Matsunaga N Radiology; 1999 Jul; 212(1):235-40. PubMed ID: 10405747 [TBL] [Abstract][Full Text] [Related]
7. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol]. De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589 [TBL] [Abstract][Full Text] [Related]
8. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. Krinsky GA; Israel G AJR Am J Roentgenol; 2003 Apr; 180(4):1023-7. PubMed ID: 12646448 [TBL] [Abstract][Full Text] [Related]
9. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [TBL] [Abstract][Full Text] [Related]
10. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119 [TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999 [TBL] [Abstract][Full Text] [Related]
12. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. Rode A; Bancel B; Douek P; Chevallier M; Vilgrain V; Picaud G; Henry L; Berger F; Bizollon T; Gaudin JL; Ducerf C J Comput Assist Tomogr; 2001; 25(3):327-36. PubMed ID: 11351179 [TBL] [Abstract][Full Text] [Related]
13. T2-weighted MR imaging in the assessment of cirrhotic liver. Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306 [TBL] [Abstract][Full Text] [Related]
14. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. Lee MH; Kim SH; Park MJ; Park CK; Rhim H AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534 [TBL] [Abstract][Full Text] [Related]
15. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US. Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Krinsky GA; Lee VS; Theise ND; Weinreb JC; Rofsky NM; Diflo T; Teperman LW Radiology; 2001 May; 219(2):445-54. PubMed ID: 11323471 [TBL] [Abstract][Full Text] [Related]
17. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154 [TBL] [Abstract][Full Text] [Related]
18. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173 [TBL] [Abstract][Full Text] [Related]